Skip to main content
Top
Published in: Indian Journal of Gastroenterology 6/2013

01-11-2013 | EDITORIAL

Endoscopic “crossroads” in the management of malignant hilar strictures

Authors: Shajan Peter, Charles M. Wilcox

Published in: Indian Journal of Gastroenterology | Issue 6/2013

Login to get access

Excerpt

Malignant biliary strictures can result from primary or metastatic disease processes of the intrahepatic or extrahepatic duct(s) [1]. Hilar cholangiocarcinomas are the most common type of primary extrahepatic bile duct cancers occurring at or near the junction of the right and left hepatic ducts or common hepatic duct. The modified Bismuth–Corlett system classifies such tumor into four types based on the extent of these lesions (types 1–4). These can present with symptoms of biliary obstruction, and accurate diagnosis and staging are needed for further management. The majority of hilar lesions are advanced and unresectable at the time of diagnosis, requiring palliative management. Palliative biliary drainage is effective in relieving obstructive symptoms, improving quality of life though there is no benefit on survival [2]. An endoscopic approach may be preferred to surgical or percutaneous methods and depends on the extent of the tumor and operability of the patient. …
Literature
2.
go back to reference Larghi A, Tringali A, Lecca PG, Giordano M, Costamagna G. Management of hilar biliary strictures. Am J Gastroenterol. 2008;103:458–73.PubMedCrossRef Larghi A, Tringali A, Lecca PG, Giordano M, Costamagna G. Management of hilar biliary strictures. Am J Gastroenterol. 2008;103:458–73.PubMedCrossRef
3.
go back to reference Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2013;28:593–607.PubMedCrossRef Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2013;28:593–607.PubMedCrossRef
4.
go back to reference Dumonceau JM, Tringali A, Blero D, et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012;44:277–98.PubMedCrossRef Dumonceau JM, Tringali A, Blero D, et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012;44:277–98.PubMedCrossRef
5.
go back to reference Perdue DG, Freeman ML, DiSario JA, et al. Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study. J Clin Gastroenterol. 2008;42:1040–6.PubMedCrossRef Perdue DG, Freeman ML, DiSario JA, et al. Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study. J Clin Gastroenterol. 2008;42:1040–6.PubMedCrossRef
6.
go back to reference Wagner HJ, Knyrim K, Vakil N, Klose KJ. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy. 1993;25:213–8.PubMedCrossRef Wagner HJ, Knyrim K, Vakil N, Klose KJ. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy. 1993;25:213–8.PubMedCrossRef
7.
go back to reference De Palma GD, Galloro G, Siciliano S, Iovino P, Catanzano C. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001;53:547–53.PubMedCrossRef De Palma GD, Galloro G, Siciliano S, Iovino P, Catanzano C. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001;53:547–53.PubMedCrossRef
8.
go back to reference Webb K, Saunders M. Endoscopic management of malignant bile duct strictures. Gastrointest Endosc Clin N Am. 2013;23:313–31.PubMedCrossRef Webb K, Saunders M. Endoscopic management of malignant bile duct strictures. Gastrointest Endosc Clin N Am. 2013;23:313–31.PubMedCrossRef
9.
go back to reference Puli SR, Kalva N, Pamulaparthy SR, et al. Bilateral and unilateral stenting for malignant hilar obstruction: a systematic review and meta-analysis. Indian J Gastroenterol. 2013; 32. doi:10.1007/s12664-013-0413-3. Puli SR, Kalva N, Pamulaparthy SR, et al. Bilateral and unilateral stenting for malignant hilar obstruction: a systematic review and meta-analysis. Indian J Gastroenterol. 2013; 32. doi:10.​1007/​s12664-013-0413-3.
10.
go back to reference Hong W, Sun X, Zhu Q. Endoscopic stenting for malignant hilar biliary obstruction: should it be metal or plastic and unilateral or bilateral? Eur J Gastroenterol Hepatol. 2013. doi:10.1097/MEG.0b013e328360b9ec. Hong W, Sun X, Zhu Q. Endoscopic stenting for malignant hilar biliary obstruction: should it be metal or plastic and unilateral or bilateral? Eur J Gastroenterol Hepatol. 2013. doi:10.​1097/​MEG.​0b013e328360b9ec​.
11.
go back to reference Dowsett JF, Vaira D, Hatfield AR, et al. Endoscopic biliary therapy using the combined percutaneous and endoscopic technique. Gastroenterology. 1989;96:1180–6.PubMed Dowsett JF, Vaira D, Hatfield AR, et al. Endoscopic biliary therapy using the combined percutaneous and endoscopic technique. Gastroenterology. 1989;96:1180–6.PubMed
12.
go back to reference Akamatsu N, Sugawara Y, Osada H, et al. Diagnostic accuracy of multidetector-row computed tomography for hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2010;25:731–7.PubMedCrossRef Akamatsu N, Sugawara Y, Osada H, et al. Diagnostic accuracy of multidetector-row computed tomography for hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2010;25:731–7.PubMedCrossRef
13.
go back to reference Vienne A, Hobeika E, Gouya H, et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc. 2010;72:728–35.PubMedCrossRef Vienne A, Hobeika E, Gouya H, et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc. 2010;72:728–35.PubMedCrossRef
14.
go back to reference Yasuda I, Mukai T, Moriwaki H. Unilateral versus bilateral endoscopic biliary stenting for malignant hilar biliary strictures. Dig Endosc. 2013;25 Suppl 2:81–5.PubMedCrossRef Yasuda I, Mukai T, Moriwaki H. Unilateral versus bilateral endoscopic biliary stenting for malignant hilar biliary strictures. Dig Endosc. 2013;25 Suppl 2:81–5.PubMedCrossRef
Metadata
Title
Endoscopic “crossroads” in the management of malignant hilar strictures
Authors
Shajan Peter
Charles M. Wilcox
Publication date
01-11-2013
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 6/2013
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-013-0418-y

Other articles of this Issue 6/2013

Indian Journal of Gastroenterology 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine